Search Results for "Neupro"

22:51 EST 30th November 2015 | BioPortfolio

Matching Channels


Matching News

UCB's Neupro meets in Chinese Phase III PD trial

UCB Group (Euronext:UCB) reported detailed data from a Phase III trial of Neupro rotigotine in Chinese patients with early stage Parkinson's disease (PD). The company announced top-line results in Feb...

UCB Patch Product for Parkinson's Passes China Phase III Test

UCB, the Belgian biopharma, reported positive results from a China Phase III trial of its transdermal patch product, NEUPRO®, a treatment for early stage Parkinson's disease. NEUPRO (rotigotine) i...

BRIEF-UCB announces data from Neupro phase 3 study

* Announces first presentation of data from Neupro (rotigotine transdermal patch) phase 3 study in China at international congress

Neupro rotigotine: Phase III data

UCB gains after boosting guidance

UCB Group (Euronext:UCB) gained EUR 4.29 to EUR 75.81 on Wednesday after reporting 3Q15 earnings and raising its guidance for 2015. The company raised its revenue guidance to EUR 3.75 billion ($4.14 b...

Matching PubMed Articles


Search Whole site using Google


Advertisement Advertisement